type here...

Health Care

Coronavirus

Challenges to Sound Global Governance for Health

Lawrence O. Gostin
In an excerpt from his new book, Global Health Security: A Blueprint for the Future, Lawrence O. Gostin examines the challenges and...
Read more
Antitrust and Competition

Antitrust Enforcement Is Not Enough to Address Anticompetitive Conduct in Pharmaceutical Markets. Market-Oriented Legal Reform is Needed.

Alden Abbott
Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in...
Read more
Antitrust and Competition

Competition Problems in Prescription Drug Market

Michael Kades
Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies...
Read more
Antitrust and Competition

The Unchecked Market Power of the American Health Care System

David Ennis
Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health...
Read more
Antitrust and Competition

Why the FTC Should Consider Size in Drug Mergers

Patricia M. Danzon, Michael A. Carrier
Large pharmaceutical firms retain their dominance through size-related advantages in three areas: contracting, marketing and selling, and financing. When reviewing pharmaceutical mergers,...
Read more
Antitrust and Competition

The Covid-19 Pandemic Should Not Delay Actions to Prevent Anticompetitive Consolidation in US Health Care Markets

Leemore Dafny
Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve...
Read more
Antitrust and Competition

More Than 20 Years of Consolidation Have Led to a Dysfunctional Health Care Market

Martin Gaynor
The US health care system is based on markets, which do not function as well as they could, or should. Prices are...
Read more
Antitrust and Competition

Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?

Tim Greaney
It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is...
Read more
Antitrust and Competition

Opening the Black Box: The Hidden Costs of Data-Driven Mergers in Health Care

Theodosia Stavroulaki
Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without...
Read more
Antitrust and Competition

Preventing Drug Shortages and Saving Lives: The Role of Quality and Reliability Standards

Rena Conti, Fiona Scott Morton, Adam Kroetsch, Stephen Colvill, Mark Rosenberg
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but...
Read more
123Page 1 of 3

Latest news

Academic Capture

Academic Gatekeepers, Real and Imagined, Are Threatening the Credibility of the Field of Political Finance 


Renée Adams
One objective of political finance is to hold power to account. However, gatekeeping, both direct and indirect, is keeping important work from...
Read more
News

A Call for Comments: Have You Been Affected by Academic Gatekeeping?

Luigi Zingales
On Friday, ProMarket published a piece by Renée Adams about the impact of academic gatekeeping in the political finance. Do you have...
Read more
Antitrust and Competition

How Big Data Fuels Big Tech’s Anticompetitive Conduct and Gatekeeping Power

Charlotte Slaiman
Achieving a truly open internet is only possible through robust online competition free from the control of today’s digital gatekeepers like Facebook...
Read more
Antitrust and Competition

The Corporate Power Narrative: How Corporations Benefit from Economic Globalization

Anthea Roberts, Nicolas Lamp
In an excerpt from their new book, Six Faces of Globalization: Who Wins, Who Loses, and Why It Matters, Anthea Roberts and...
Read more
Corporate Governance

Managers Should Satisfy Only the Ethically Permissible Preferences of Shareholders

Santiago Mejia
Oliver Hart and Luigi Zingales have proposed a revision to the dominant model of the objective of the firm, most famously defended...
Read more
Economic History Series

Plagues Upon the Earth: How Wealth Intersects With Mortality

Kyle Harper
Kyle Harper’s new book, Plagues Upon the Earth: Disease and the Course of Human History, shows that the story of disease is...
Read more
Capitalisn't

What Accounts for the Gender Equality Among Pharmacists?

Claudia Goldin
In her new book Career and Family: Women’s Century-Long Journey toward Equity, Harvard Professor Claudia Goldin traces how generations of women have...
Read more
View All

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.

About Us

Categories

What we are readingAntitrust and CompetitionNewsRegulatory CaptureMediaRent seeking